TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29688768

Group type: EXPERIMENTAL
Intervention: Herbal compresses
Number of subjects: 500

Group type: COMPARATOR
Intervention: Hot compresses
Number of subjects: 500
Study: 28230020

Group type: EXPERIMENTAL
Intervention: TACE combined with MWA
Number of subjects: 3000

Group type: COMPARATOR
Intervention: TACE
Number of subjects: 3000
Study: 24551257

Group type: EXPERIMENTAL
Intervention: High-frequency electrocauterization (EC) followed by daily moist-wound-treatment (MWT) with DAC N-055 (group I)
Number of subjects: 113

Group type: COMPARATOR
Intervention: High-frequency electrocauterization (EC) followed by daily moist-wound-treatment (MWT) without DAC N-055 (group II)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: High-frequency electrocauterization (EC) with DAC N-055
Number of subjects: 113

Group type: COMPARATOR
Intervention: High-frequency electrocauterization (EC) without DAC N-055
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups (group I and group II)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: High-frequency electrocauterization (EC) with DAC N-055 (group I)
Number of subjects: 113

Group type: COMPARATOR
Intervention: High-frequency electrocauterization (EC) without DAC N-055 (group II)
Number of subjects: 113
Study: 22343153

Group type: EXPERIMENTAL
Intervention: Fine‐motor eye exercises (n=18)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No exercise (n=9)
Number of subjects: 27
Study: 20363903

Group type: EXPERIMENTAL
Intervention: Exposure to billing time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental manipulation of billing time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual differences in valuing money
Number of subjects: 0
Study: 17727960

Group type: EXPERIMENTAL
Intervention: Moderate/hard exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Very-light exercise
Number of subjects: 18
Study: 15963870

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nebulized morphine
Number of subjects: 11
Study: 12576806

Group type: EXPERIMENTAL
Intervention: 2 weeks stenting (group 1)
Number of subjects: 57

Group type: COMPARATOR
Intervention: 4 weeks stenting (group 2)
Number of subjects: 57
Study: 10588116

Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study: 9171045

Group type: EXPERIMENTAL
Intervention: Electrically active toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inactive toothbrush
Number of subjects: 0
Study: 8340055

Group type: EXPERIMENTAL
Intervention: Ribavirin (0.8 to 1.0 gm/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Interferon-beta (3 mU three times a week intravenously)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of ribavirin and interferon-beta
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 3089939

Group type: COMPARATOR
Intervention: LAF (laminar air flow isolation)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: LAF + PSA (laminar air flow isolation plus prophylactic systemic antibiotics)
Number of subjects: 122
Study: 29300962

Group type: EXPERIMENTAL
Intervention: 10 mg THC
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 25 mg THC
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 50 mg THC
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 50 ng/mL cutoff
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 ng/mL cutoff
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 ng/mL cutoff
Number of subjects: 18
Study: 27552840

Group type: EXPERIMENTAL
Intervention: Tailored intervention (three participatory workshops and organization-wide educational activities)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard care (print resources)
Number of subjects: 16
Study: 25425371

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography in intubated patients under controlled mechanical ventilation (group 1)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiography in intubated patients under pressure support ventilation (group 2)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: No ventilation support in patients (group 3)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Hypovolemia before the session in patients without mechanical ventilation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Overall comparison of groups
Number of subjects: 54
Study: 23259002

Group type: EXPERIMENTAL
Intervention: Essential oil inhalation (lavender, ylang‐ylang, marjoram, neroli blended in a ratio of 20:15:10:2)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Essential oil inhalation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (artificial fragrance)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 83
Study: 20450989

Group type: EXPERIMENTAL
Intervention: Pre-operative MRCP in group I (125 patients)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy without pre-operative MRCP in group II (125 patients)
Number of subjects: 250
Study: 18183613

Group type: EXPERIMENTAL
Intervention: HP eradication therapy (amoxicillin, clarithromycin, and omeprazole) for 2 weeks
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: HP eradication therapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: HP-negative patients
Number of subjects: 129
Study: 15925483

Group type: EXPERIMENTAL
Intervention: Acupuncture on acupoints Renyin (Stomach Channel 9), Lieque (Lung Channel 7), and Zhaohai (Kidney Channel 6)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo acupuncture on acupoints Houxi (Small Intestine Channel 3) and Kunlun (Bladder Channel 60)
Number of subjects: 24
Study: 12944595

Group type: EXPERIMENTAL
Intervention: 20 mg or 40 mg of hyoscine butylbromide
Number of subjects: 136

Group type: COMPARATOR
Intervention: hyoscine butylbromide
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: rectal balloon catheter
Number of subjects: 136
Study: 10102972

Group type: EXPERIMENTAL
Intervention: Mesalazine 2 g gel enema
Number of subjects: 103

Group type: COMPARATOR
Intervention: Mesalazine 2 g foam enema
Number of subjects: 103
Study: 7928148

Group type: EXPERIMENTAL
Intervention: Fibrin sealant spraying
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no fibrin sealant)
Number of subjects: 77

Group type: COMPARATOR
Intervention: No liver mobilization
Number of subjects: 77
Study: 2484394

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (15 ppm anhydrous sodium selenite in table salt)
Number of subjects: 20847

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 20847

Group type: COMPARATOR
Intervention: Normal table salt (control)
Number of subjects: 20847
Study: 1105752

Group type: EXPERIMENTAL
Intervention: Lumbar traction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no traction)
Number of subjects: 0
Study: 31387756

Group type: EXPERIMENTAL
Intervention: HIPEC (cisplatin 50 mg/m2 + doxorubicin 50 mg/m2, 42°C, 1 h) combined with radical surgery
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (radical surgery only)
Number of subjects: 154
Study: 28029189

Group type: EXPERIMENTAL
Intervention: Group RS (Resilience Light Cure Band Cement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group RMO (RMO Band Cement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group CK (Crosslink Orthodontic Band Cement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group TP (Transbond Plus Light Cure Band)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group C (Control-polyethylene)
Number of subjects: 0
Study: 26398263

Group type: EXPERIMENTAL
Intervention: Direct training with vocal exercises (DTG, n=13)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Indirect training with vocal orientations (ITG, n=12)
Number of subjects: 25
Study: 23441809

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 21935504

Group type: EXPERIMENTAL
Intervention: Elastomeric-ligated brackets
Number of subjects: 13

Group type: COMPARATOR
Intervention: Self-ligating brackets
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: DIAGNOdent measurements
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Photographic evaluation
Number of subjects: 13
Study: 18588449

Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with cisplatin/5-fluorouracil (PF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin/5-fluorouracil (PF)
Number of subjects: 0
Study: 16565124

Group type: EXPERIMENTAL
Intervention: Decision support software
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Practice based workshops
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electronic tutorial
Number of subjects: 36
Study: 15799932

Group type: EXPERIMENTAL
Intervention: On-pump technique
Number of subjects: 324

Group type: COMPARATOR
Intervention: Off-pump technique
Number of subjects: 324
Study: 10902462

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiofrequency thermal ablation (RFTA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment strategies (TACE and PEI or RFTA)
Number of subjects: 0
Study: 9293628

Group type: EXPERIMENTAL
Intervention: Collaborative group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nominal group
Number of subjects: 0
Study: 7955267

Group type: EXPERIMENTAL
Intervention: Maze procedure
Number of subjects: 46
Study: 3799443

Group type: EXPERIMENTAL
Intervention: Indecainide, 1 mg/kg intravenously
Number of subjects: 15

Group type: COMPARATOR
Intervention: Procainamide, 1000 mg intravenously
Number of subjects: 15
Study: 30111521

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 931

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 931
Study: 28549637

Group type: EXPERIMENTAL
Intervention: Maternal vitamin D supplementation
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control group (infant vitamin D supplementation)
Number of subjects: 234
Study: 26516711

Group type: EXPERIMENTAL
Intervention: 0.014‐inch superelastic NiTi
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.014‐inch thermoelastic NiTi
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.014‐inch conventional NiTi
Number of subjects: 75
Study: 23273227

Group type: EXPERIMENTAL
Intervention: Comprehensive healthy lifestyle program (IHHP)
Number of subjects: 2180000

Group type: COMPARATOR
Intervention: Reference area
Number of subjects: 2180000
Study: 21968670

Group type: EXPERIMENTAL
Intervention: Topical treatment applied weekly for six months
Number of subjects: 63
Study: 18617377

Group type: EXPERIMENTAL
Intervention: 1.4 g/day SINETROL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16955182

Group type: EXPERIMENTAL
Intervention: Electrical ear acupuncture on right ear
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Electrical ear acupuncture on left ear
Number of subjects: 32

Group type: COMPARATOR
Intervention: No acupuncture (control)
Number of subjects: 32
Study: 12729523

Group type: EXPERIMENTAL
Intervention: Standard enteral formula (3 cans/day, 250 ml per can)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Isolated nutritional counselling (unsupplemented group)
Number of subjects: 70
Study: 10671303

Group type: EXPERIMENTAL
Intervention: 2 microg GM‐CSF/kg b.w. daily for 6 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: GM‐CSF/IFNalpha2b combination
Number of subjects: 45

Group type: COMPARATOR
Intervention: IFNalpha2b monotherapy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: GM‐CSF therapy
Number of subjects: 45
Study: 8841206

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 1739366

Group type: EXPERIMENTAL
Intervention: Mupirocin calcium ointment applied to the anterior part of the nares for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6352728

Group type: EXPERIMENTAL
Intervention: Meal size (12.5%, 25%, and 50% of total calories, 30 Kcal/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sequence of meal ingestion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Time of day of meal ingestion
Number of subjects: 8
Study: 31560700

Group type: EXPERIMENTAL
Intervention: abacavir/lamivudine + raltegravir
Number of subjects: 46

Group type: COMPARATOR
Intervention: abacavir/lamivudine + darunavir/r
Number of subjects: 46
Study: 29453431

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (HRLGG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (HRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control (HC) infants
Number of subjects: 0
Study: 27004631

Group type: EXPERIMENTAL
Intervention: Footwear with dorsal fixation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Slippers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bare feet
Number of subjects: 30
Study: 25130226

Group type: EXPERIMENTAL
Intervention: Physician-based intervention guided by social cognitive theory (SCT) including two 45-minute in-office training sessions and a dual-language communication guide.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 25
Study: 21817954

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine coadministered with Tdap and/or MCV4
Number of subjects: 1283

Group type: COMPARATOR
Intervention: HPV-16/18 AS04-adjuvanted vaccine alone
Number of subjects: 1283

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine coadministered with Tdap
Number of subjects: 1283

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine coadministered with MCV4
Number of subjects: 1283
Study: 19328268

Group type: EXPERIMENTAL
Intervention: South Beach diet
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ornish diet
Number of subjects: 18

Group type: COMPARATOR
Intervention: Atkins diet
Number of subjects: 18

Group type: COMPARATOR
Intervention: Brachial artery testing
Number of subjects: 18
Study: 17047484

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 114
Study: 15364708

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 1200 mg/d plus vitamin A
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control capsules plus vitamin A
Number of subjects: 221
Study: 11046101

Group type: EXPERIMENTAL
Intervention: Tasosartan (100 mg p.o.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tasosartan (50 mg i.v.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoltasosartan (2.5 mg i.v.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: In vitro blockade by Tasosartan
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: In vitro blockade by Enoltasosartan
Number of subjects: 12
Study: 9333103

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg/day for 8 days)
Number of subjects: 12
Study: 8467987

Group type: EXPERIMENTAL
Intervention: Exercise and diet group (EXE)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Insulin and diet group (INS)
Number of subjects: 41
Study: 3532592

Group type: EXPERIMENTAL
Intervention: 1600 mg cimetidine (400 mg q.i.d.) daily
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: 800 mg cimetidine (400 mg b.i.d.) daily
Number of subjects: 323
Study: 30124952

Group type: EXPERIMENTAL
Intervention: Glucocorticoid combined with MMF therapy (1-1.5 g/day)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Glucocorticoid monotherapy (0.6-0.8 mg/(kg·day) and tapered gradually)
Number of subjects: 69
Study: 28858120

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave therapy (ESWT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 26098848

Group type: EXPERIMENTAL
Intervention: Brief Personalised Intervention (BPI)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Active Control (alcohol-related quiz on the UK Department of Health's Change4Life website)
Number of subjects: 103
Study: 23100282

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily
Number of subjects: 18705

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18705
Study: 21614906

Group type: EXPERIMENTAL
Intervention: morphine + acetaminophen + ketoprofen
Number of subjects: 128

Group type: COMPARATOR
Intervention: morphine + metamizol + ketoprofen
Number of subjects: 128
Study: 19802545

Group type: EXPERIMENTAL
Intervention: Qingzhen Decoction (QZD)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (routine therapy only)
Number of subjects: 62
Study: 16963345

Group type: EXPERIMENTAL
Intervention: Intervention group received four stage-based newsletters, one motivational interview, and an individually tailored e-mail follow-up over a 4-month period.
Number of subjects: 437

Group type: COMPARATOR
Intervention: Control group received only assessment at baseline and at completion.
Number of subjects: 437
Study: 15289245

Group type: EXPERIMENTAL
Intervention: Coping skills intervention delivered in 3 modules over 24 sessions
Number of subjects: 423

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 423
Study: 11346243

Group type: EXPERIMENTAL
Intervention: Preinfarction angina
Number of subjects: 119

Group type: COMPARATOR
Intervention: No preinfarction angina
Number of subjects: 119
Study: 9225507

Group type: EXPERIMENTAL
Intervention: Conventional kinesitherapy with magnetotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional kinesitherapy without magnetotherapy
Number of subjects: 60
Study: 8317683

Group type: EXPERIMENTAL
Intervention: Enflurane anesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Controlled ventilation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both enflurane and isoflurane
Number of subjects: 40
Study: 3107365

Group type: EXPERIMENTAL
Intervention: Surgical therapy
Number of subjects: 427

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 427
Study: 31169888

Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (3 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise (post-intervention)
Number of subjects: 0
Study: 29128651

Group type: EXPERIMENTAL
Intervention: Multi-modal education (MME) intervention including a structured web-course, role play exercise, WebPatientEncounter, and enhanced outpatient clerkship.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Traditional education (TE)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Multi-modal education (MME) intervention
Number of subjects: 8
Study: 27917806

Group type: EXPERIMENTAL
Intervention: Plain articaine 40 mg mixed with fentanyl 20 µg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plain levobupivacaine 10 mg mixed with fentanyl 20 µg
Number of subjects: 100
Study: 24911576

Group type: EXPERIMENTAL
Intervention: morphine 50 mg + ethanol 0.7 g/kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: morphine 50 mg + ethanol placebo
Number of subjects: 16

Group type: COMPARATOR
Intervention: morphine placebo + ethanol 0.7 g/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: morphine 30 mg or 80 mg (alone and in combination with ethanol)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: morphine and ethanol (combined)
Number of subjects: 16
Study: 22429177

Group type: EXPERIMENTAL
Intervention: ESPO group (expert demonstration, self-assessment, peer feedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ESPO group
Number of subjects: 0

Group type: COMPARATOR
Intervention: EO group (expert demonstration only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ESO group (expert demonstration, self-assessment, expert feedback)
Number of subjects: 0
Study: 19887878

Group type: EXPERIMENTAL
Intervention: 1.25 mg (0.1 ml) bevacizumab
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.1 ml balanced salt solution
Number of subjects: 30
Study: 18647814

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 17094040

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with optimal lung volume strategy (OLVS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional ventilation or high-frequency oscillatory ventilation
Number of subjects: 10
Study: 14641427

Group type: EXPERIMENTAL
Intervention: Ledermix paste
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste
Number of subjects: 221

Group type: COMPARATOR
Intervention: No dressing
Number of subjects: 221
Study: 10675071

Group type: EXPERIMENTAL
Intervention: ramipril (10 mg/day)
Number of subjects: 3577
Study: 9410237

Group type: EXPERIMENTAL
Intervention: Flurbiprofen ED twice a day from the first preoperative day to the third postoperative day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Artificial tears twice a day from the first preoperative day to the third postoperative day
Number of subjects: 100
Study: 8460605

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified rusk
Number of subjects: 226

Group type: COMPARATOR
Intervention: Unfortified rusk
Number of subjects: 226
Study: 3987415

Group type: EXPERIMENTAL
Intervention: Active exposure to the Brazelton Neonatal Behavior Assessment (parents actively eliciting responses from newborns)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive exposure to the Brazelton Neonatal Behavior Assessment (parents listening to a verbal description of infant performance)
Number of subjects: 0
Study: 31896832

Group type: EXPERIMENTAL
Intervention: Lidocaine 5% spray for 8 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (alcohol spray) for 8 weeks
Number of subjects: 150
Study: 29653857

Group type: EXPERIMENTAL
Intervention: FOLFOX6/Bevacizumab with pelareorep (n=51)
Number of subjects: 103

Group type: COMPARATOR
Intervention: FOLFOX6/Bevacizumab without pelareorep (n=52)
Number of subjects: 103